EP1765292
Lyfjasamsetning sem hindrar misnotkun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.6.2005EP published:
4.10.2017EP application number:
05759527.4
EP translation filed:
13.12.2017Grant published:
15.1.2018EPO information:
European Patent Register
Max expiry date:
9.6.2025Expiry date:
9.6.2019
Title:
ABUSE-DETERRENT DRUG FORMULATIONS
Timeline
Today
10.6.2005EP application
4.10.2017EP Publication
13.12.2017Translation submitted
15.1.2018Registration published
9.6.2019Expires
Owner
Name:
Collegium Pharmaceutical, Inc.Address:
400 Highland Corporate Drive, 02864, Cumberland, RI, US
Inventor
Name:
HIRSH, JaneAddress:
Wellesley, MA, US
Name:
FLEMING, Alison, B.Address:
North Attleboro, MA, US
Name:
RARIY, Roman, V.Address:
Allston, MA, US
Name:
KLIBANOV, Alexander, M.Address:
Boston, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
579191 PDate:
12.6.2004Country:
US
Classification
Categories:
A61K 9/14, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 14.5.2018
Expires: 9.6.2019
Payer: Árnason Faktor